Published in Nucleic Acids Res on October 15, 1999
Cell senescence and telomere shortening induced by a new series of specific G-quadruplex DNA ligands. Proc Natl Acad Sci U S A (2002) 1.75
Easily denaturing nucleic acids derived from intercalating nucleic acids: thermal stability studies, dual duplex invasion and inhibition of transcription start. Nucleic Acids Res (2005) 0.85
Quantitative assessment of the use of modified nucleoside triphosphates in expression profiling: differential effects on signal intensities and impacts on expression ratios. BMC Biotechnol (2002) 0.75
A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science (1995) 15.20
Construction of T-vectors, a rapid and general system for direct cloning of unmodified PCR products. Nucleic Acids Res (1991) 9.56
Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science (1997) 7.95
Directional cloning of DNA fragments at a large distance from an initial probe: a circularization method. Proc Natl Acad Sci U S A (1984) 7.38
The mammalian gene collection. Science (1999) 7.19
The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals. Nat Genet (1995) 5.83
Mutations in the human Jagged1 gene are responsible for Alagille syndrome. Nat Genet (1997) 5.58
The molecular genetics of human hemoglobin. Prog Nucleic Acid Res Mol Biol (1984) 5.50
Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search. Science (1996) 5.06
Determination of ancestral alleles for human single-nucleotide polymorphisms using high-density oligonucleotide arrays. Nat Genet (1999) 4.79
Identification of mutations in regions corresponding to the two putative nucleotide (ATP)-binding folds of the cystic fibrosis gene. Proc Natl Acad Sci U S A (1990) 4.74
Mutation analysis for heterozygote detection and the prenatal diagnosis of cystic fibrosis. N Engl J Med (1990) 4.60
Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients. Nature (1992) 4.42
Direct sequencing of enzymatically amplified human genomic DNA. Proc Natl Acad Sci U S A (1988) 4.41
TEL1, an S. cerevisiae homolog of the human gene mutated in ataxia telangiectasia, is functionally related to the yeast checkpoint gene MEC1. Cell (1995) 4.34
Detection of heterozygous mutations in BRCA1 using high density oligonucleotide arrays and two-colour fluorescence analysis. Nat Genet (1996) 4.19
Genetic discrimination and health insurance: an urgent need for reform. Science (1995) 4.08
Fusion between transcription factor CBF beta/PEBP2 beta and a myosin heavy chain in acute myeloid leukemia. Science (1993) 3.88
Construction of a general human chromosome jumping library, with application to cystic fibrosis. Science (1987) 3.87
Characterization of the CHD family of proteins. Proc Natl Acad Sci U S A (1997) 3.76
Correction of the cystic fibrosis defect in vitro by retrovirus-mediated gene transfer. Cell (1990) 3.70
Phylogenetic footprinting reveals a nuclear protein which binds to silencer sequences in the human gamma and epsilon globin genes. Mol Cell Biol (1992) 3.57
A de novo Alu insertion results in neurofibromatosis type 1. Nature (1991) 3.29
Menin interacts with the AP1 transcription factor JunD and represses JunD-activated transcription. Cell (1999) 3.16
Chloride conductance expressed by delta F508 and other mutant CFTRs in Xenopus oocytes. Science (1991) 3.12
The complete sequence of the coding region of the ATM gene reveals similarity to cell cycle regulators in different species. Hum Mol Genet (1995) 3.05
Characteristics of prostate cancer in families potentially linked to the hereditary prostate cancer 1 (HPC1) locus. JAMA (1997) 2.73
Positional cloning: let's not call it reverse anymore. Nat Genet (1992) 2.69
Strategies for mapping and cloning macroregions of mammalian genomes. Methods Enzymol (1987) 2.68
Dinucleotide repeat polymorphisms at the D17S250 and D17S261 loci. Nucleic Acids Res (1990) 2.62
A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors. Proc Natl Acad Sci U S A (2001) 2.57
Genetic counseling for families with inherited susceptibility to breast and ovarian cancer. JAMA (1993) 2.51
Detection of eight BRCA1 mutations in 10 breast/ovarian cancer families, including 1 family with male breast cancer. Am J Hum Genet (1995) 2.42
Menin, the product of the MEN1 gene, is a nuclear protein. Proc Natl Acad Sci U S A (1998) 2.39
A point mutation in the A gamma-globin gene promoter in Greek hereditary persistence of fetal haemoglobin. Nature (1985) 2.33
A phase I/II study of trichosanthin treatment of HIV disease. AIDS (1990) 2.26
Molecular pathogenesis of the chromosome 16 inversion in the M4Eo subtype of acute myeloid leukemia. Blood (1995) 2.23
Strategies for mutational analysis of the large multiexon ATM gene using high-density oligonucleotide arrays. Genome Res (1998) 2.17
Somatic deletion of the neurofibromatosis type 1 gene in a neurofibrosarcoma supports a tumour suppressor gene hypothesis. Nat Genet (1993) 2.10
Mutational analysis using oligonucleotide microarrays. J Med Genet (1999) 2.05
cDNA cloning of the type 1 neurofibromatosis gene: complete sequence of the NF1 gene product. Genomics (1991) 2.03
Substrate nucleotide-determined non-templated addition of adenine by Taq DNA polymerase: implications for PCR-based genotyping and cloning. Biotechniques (1996) 2.02
Muscarinic acetylcholine receptor subtypes as agonist-dependent oncogenes. Proc Natl Acad Sci U S A (1991) 2.00
MLH3: a DNA mismatch repair gene associated with mammalian microsatellite instability. Nat Genet (2000) 2.00
BRCA1--lots of mutations, lots of dilemmas. N Engl J Med (1996) 1.94
Type 2 diabetes: evidence for linkage on chromosome 20 in 716 Finnish affected sib pairs. Proc Natl Acad Sci U S A (1999) 1.91
Evolutionary sequence comparisons using high-density oligonucleotide arrays. Nat Genet (1998) 1.90
Somatic mutation of the MEN1 gene in parathyroid tumours. Nat Genet (1997) 1.90
Localization of cystic fibrosis transmembrane conductance regulator mRNA in the human gastrointestinal tract by in situ hybridization. J Clin Invest (1994) 1.86
Failure of embryonic hematopoiesis and lethal hemorrhages in mouse embryos heterozygous for a knocked-in leukemia gene CBFB-MYH11. Cell (1996) 1.84
G gamma beta+ hereditary persistence of fetal hemoglobin: cosmid cloning and identification of a specific mutation 5' to the G gamma gene. Proc Natl Acad Sci U S A (1984) 1.84
Fine-structure genetic mapping of human chromosomes using the polymerase chain reaction on single sperm: experimental design considerations. Am J Hum Genet (1989) 1.83
Somatic mutations of the MEN1 tumor suppressor gene in sporadic gastrinomas and insulinomas. Cancer Res (1997) 1.82
A transcript map for the 2.8-Mb region containing the multiple endocrine neoplasia type 1 locus. Genome Res (1997) 1.82
Multiple endocrine neoplasia type 1: clinical and genetic topics. Ann Intern Med (1998) 1.81
Localization of the cystic fibrosis transmembrane conductance regulator in human bile duct epithelial cells. Gastroenterology (1993) 1.79
Germline mutations of the MEN1 gene in familial multiple endocrine neoplasia type 1 and related states. Hum Mol Genet (1997) 1.77
Familiality of quantitative metabolic traits in Finnish families with non-insulin-dependent diabetes mellitus. Finland-United States Investigation of NIDDM Genetics (FUSION) Study investigators. Hum Hered (1999) 1.76
Somatic mutations in the BRCA1 gene in sporadic ovarian tumours. Nat Genet (1995) 1.75
Hereditary hemochromatosis: gene discovery and its implications for population-based screening. JAMA (1998) 1.73
Molecular basis of defective anion transport in L cells expressing recombinant forms of CFTR. Hum Mol Genet (1993) 1.71
Identification of MEN1 gene mutations in sporadic carcinoid tumors of the lung. Hum Mol Genet (1997) 1.70
The tumor suppressor protein menin interacts with NF-kappaB proteins and inhibits NF-kappaB-mediated transactivation. Oncogene (2001) 1.69
Widespread expression of the human and rat Huntington's disease gene in brain and nonneural tissues. Nat Genet (1993) 1.67
Nuclear proteins that bind the human gamma-globin gene promoter: alterations in binding produced by point mutations associated with hereditary persistence of fetal hemoglobin. Mol Cell Biol (1988) 1.63
CFTR activation: additive effects of stimulatory and inhibitory phosphorylation sites in the R domain. Am J Physiol (1997) 1.57
Identification of the neurofibromatosis type 1 gene product. Proc Natl Acad Sci U S A (1991) 1.55
How is the Human Genome Project doing, and what have we learned so far? Proc Natl Acad Sci U S A (1995) 1.50
Direct construction of a chromosome-specific NotI linking library from flow-sorted chromosomes. Nucleic Acids Res (1989) 1.49
Bidirectional transcriptional activity of PGK-neomycin and unexpected embryonic lethality in heterozygote chimeric knockout mice. Genesis (2001) 1.46
Magnetic bead capture of expressed sequences encoded within large genomic segments. Nature (1993) 1.45
Mutations in the neurofibromatosis 1 gene in sporadic malignant melanoma cell lines. Nat Genet (1993) 1.45
A conserved alternative splice in the von Recklinghausen neurofibromatosis (NF1) gene produces two neurofibromin isoforms, both of which have GTPase-activating protein activity. Mol Cell Biol (1993) 1.43
Genetics moves into the medical mainstream. JAMA (2001) 1.41
Guidelines for human gene nomenclature. An international system for human gene nomenclature (ISGN, 1987). Cytogenet Cell Genet (1987) 1.40
The ataxia-telangiectasia gene product, a constitutively expressed nuclear protein that is not up-regulated following genome damage. Proc Natl Acad Sci U S A (1997) 1.39
Human artificial chromosomes generated by modification of a yeast artificial chromosome containing both human alpha satellite and single-copy DNA sequences. Proc Natl Acad Sci U S A (1999) 1.39
Physical mapping of the cystic fibrosis region by pulsed-field gel electrophoresis. Genomics (1988) 1.38
SacI RFLP in the human von Willebrand factor gene. Nucleic Acids Res (1987) 1.36
The neurofibromatosis type 1 gene and its protein product, neurofibromin. Neuron (1993) 1.36
Approach to genotyping errors caused by nontemplated nucleotide addition by Taq DNA polymerase. Genome Res (1995) 1.33
Human BRCA1 inhibits growth in yeast: potential use in diagnostic testing. Proc Natl Acad Sci U S A (1997) 1.32
Infantile myofibromatosis. Evidence for an autosomal-dominant disorder. Am J Surg Pathol (1984) 1.32
Mutations of the MEN1 tumor suppressor gene in pituitary tumors. Cancer Res (1997) 1.31
Cystic fibrosis transmembrane conductance regulator (CFTR) anion binding as a probe of the pore. Biophys J (1998) 1.30
Choroideremia and deafness with stapes fixation: a contiguous gene deletion syndrome in Xq21. Am J Hum Genet (1989) 1.29
Multiple endocrine neoplasia type 1: clinical and genetic features of the hereditary endocrine neoplasias. Recent Prog Horm Res (1999) 1.29
Menin molecular interactions: insights into normal functions and tumorigenesis. Horm Metab Res (2005) 1.28
Functional roles of the nucleotide-binding folds in the activation of the cystic fibrosis transmembrane conductance regulator. Proc Natl Acad Sci U S A (1993) 1.28
Early age at diagnosis in families providing evidence of linkage to the hereditary prostate cancer locus (HPC1) on chromosome 1. Cancer Res (1997) 1.27
The human autologous mixed lymphocyte reaction. III. Immune circuits. J Immunol (1982) 1.27
Preparing health professionals for the genetic revolution. JAMA (1997) 1.27
Cellular characterisation of the GCKR P446L variant associated with type 2 diabetes risk. Diabetologia (2011) 1.27
Physical mapping of a translocation breakpoint in neurofibromatosis. Science (1989) 1.27
The Human Genome Project: view from the National Institutes of Health. J Am Med Womens Assoc (1997) 1.25